J O Cullis
Overview
Explore the profile of J O Cullis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panwar U, Mathews C, Cullis J
Int J Lab Hematol
. 2008 Jul;
30(4):331-3.
PMID: 18665831
Cold haemagglutinin disease (CHAD) is an uncommon condition frequently associated with B-cell lymphoproliferative disorders and is refractory to conventional treatments used in autoimmune haemolytic anaemia. Rituximab has been used in...
2.
Milligan D, Grimwade D, Cullis J, Bond L, Swirsky D, Craddock C, et al.
Br J Haematol
. 2006 Oct;
135(4):450-74.
PMID: 17054678
No abstract available.
3.
Treleaven J, Cullis J, Maynard R, Bishop E, Ainsworth-Smith I, Roques A, et al.
Br J Haematol
. 2006 Feb;
132(5):552-9.
PMID: 16445827
No abstract available.
4.
5.
Cullis J, Duncombe A, Dudley J, Lumley H, Apperley J, Smith A
Br J Haematol
. 1998 Apr;
100(4):664-8.
PMID: 9531331
The refusal of Jehovah's Witnesses with leukaemia to accept transfusion provides a major clinical challenge because of the myelosuppressive effects of chemotherapy. Experience in treating five such patients is described....
6.
Parker J, Pagliuca A, Mijovic A, Cullis J, Czepulkowski B, Rassam S, et al.
Br J Haematol
. 1998 Jan;
99(4):939-44.
PMID: 9432047
Nineteen patients with high-risk myelodysplastic syndrome (MDS)/acute myeloid leukaemia (AML) received fludarabine, cytarabine, granulocyte-colony stimulating factor (G-CSF), and idarubicin chemotherapy (de novo MDS/MDS-AML, nine; relapsed/refractory MDS/AML, seven; therapy-related MDS, three)....
7.
Cullis J, Win N, Dudley J, Kaye T
Vox Sang
. 1995 Jan;
69(4):355-7.
PMID: 8751307
Delayed haemolytic transfusion reactions (DHTRs) are seen more frequently in patients with sickle cell disease (SCD) than in other groups of patients, and are characterised by a positive direct antiglobulin...
8.
van Rhee F, Lin F, Cullis J, Spencer A, Cross N, Chase A, et al.
Blood
. 1994 Jun;
83(11):3377-83.
PMID: 8193375
Fourteen patients with chronic myeloid leukemia (CML) relapsing after allogeneic bone marrow transplant (BMT) were treated with leukocyte transfusions from the original marrow donor (sibling, n = 9; volunteer unrelated,...
9.
Cullis J, Barrett A, Goldman J, Lechler R
Leukemia
. 1994 Jan;
8(1):165-70.
PMID: 8289483
Leukaemia-specific proteins may be recognized by T-lymphocytes as neoantigens if peptides corresponding to mutated sequences bind to major histocompatibility complex (MHC) molecules on leukaemic cells. We studied the ability of...
10.
Marks D, Cullis J, Ward K, Lacey S, Syzdlo R, Hughes T, et al.
Ann Intern Med
. 1993 Aug;
119(3):207-14.
PMID: 8391772
Objective: To compare the short- and medium-term complications (particularly infection) of bone marrow transplantation for chronic myeloid leukemia in patients with HLA-identical sibling donors or volunteer unrelated donors. Design: Retrospective...